Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.

Nor Rahimah AiniNorhayati Mohd NoorMohd Khairi Md DaudSarah K WiseBaharudin Abdullah

Published in: Clinical and translational allergy (2021)

Intralymphatic immunotherapy possibly has a role in the treatment of AR patients. This review found it is safe but not effective, which could be contributed by the high variation amongst the trials. Future trials should involve larger numbers of participants and report standardized administration of ILIT and outcome measures.

Keyphrases

allergic rhinitis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors